MAY 11 - 12 2016
Genetics and Genomics
49 176 41799

The LabRoots 4th Annual Genetics and Genomics free virtual conference was a wonderful event for research scientists, post docs, principal investigators, lab directors and other genetics professionals to learn about recent advances in genetics research. This year's conference highlighted some fabulous presentations from Robert Green, Amalio Telenti, David Bentley, Alexander Wait Zaranek and many more.

Watch this video to learn about some of the featured speakers.

This virtual conference is now On Demand and allows you to participate in a global setting with no travel or cost to you. You can participate in exactly those parts which you are interested in and be back at your desk or bench in an instant. Virtual events remove time and place restrictions and ensure that everyone who wants to participate can do so. This virtual conference also offers increased reach for the global genetics community with a high degree of interaction through live-streaming video and chat sessions.

Genetics plays a crucial role in the constantly growing and challenging fields of diagnosis and treatment of genetic disorders, infectious diseases and acquired diseases. This conference will focus on "Biology to the Clinic", and will highlight the topics below.

Innovations in Genomic Tools and Technologies

Genome Editing; Synthetic Biology; Methods and Technologies for Multi-Center Genetics Platforms and Research; and Moving Beyond GWAS with Functional Approaches


-Omics in Health and Disease

Single Cell Genomics; Metabolism, Mitochondria and Microbiomes; and Systems Approach to -Omics


Clinical Utility of the Newest Technologies

Radiomics/Radiogenomics; Clinical Quality Variant Annotation and Databasing; Reimbursement Issues in Clinical Molecular Diagnostics; Data Knowledge and Integration to Medicine; and Methods for Network Inference

 

Genomics in the Clinic
From Tumor Mutation Profile to Clinical Trials; Nucleic Acid Therapeutics; and Precision Medicine (including Noninvasive Pre-Symptomatic Disease Detection; Individualized Vaccines; Genotype-Phenotype Warehousing: Technologies for Large-Scale Analyses; Pediatric Genetics and Genomics; and Liquid Biopsy, Exosomes, Circulating DNA and Tumor Cells)


Genetics and Genomics conference participants benefit from interacting with field experts and networking with colleagues. Attendees can also “walk” through the virtual exhibit hall to learn about the latest in genetics and genomics tools and assays. Join LabRoots in leading progress toward understanding the genetics behind disease and treatment.

Continuing Education
By participating in this virtual event and watching webcast presentations, you can earn Free CEU, CE, and/or CME credits. To earn educational credits, you must view an entire presentation. Following the presentation you must click on the educational credit link provided for that particular speaker and follow the required process. Once you have completed the process, you will receive a certificate for the educational credit. The American Board of Genetic Counseling, certifies genetic counselors and accredits genetic counseling training programs. The National Society of Genetic Counselors (NSGC) is the professional membership association for the genetic counseling profession.

Use #LRgenetics to follow the conversation


Speakers:
  • Director, G2P Research Program (genomes2people.org), Division of Genetics, Brigham and Women's Hospital, Broad Institute, Harvard Medical School
  • Vice President & Chief Scientist, Illumina Inc.
  • Director, Informatics, Harvard Personal Genome Project, Chief Scientist and Co-founder, Curoverse
  • Head of Translational Genetics, Regeneron Genetics Center
  • Head of Genomics, Human Longevity, Inc., Research Scientist, J Craig Venter Institute
  • Director, Division of Bioinformatics and Biostatistics, National Center for Toxicological Research (NCTR), FDA
  • Director/PI, Computational Imaging and Bioinformatics Laboratory (CIBL), Assistant Professor of Radiation Oncology, Harvard Medical School, Brigham and Women's Hospital, Dana Farber Cancer In
  • Director, Informatics, Inova Health
  • Assistant Professor, Director of Clinical Genome Informatics, Department of Genetics and Genomic Sciences, Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mou
  • Chief Executive Officer, Genospace
  • Director of Laboratory Operations, Center for Pediatric Genomic Medicine, Children's Mercy Hospital, Assistant Professor, University of Missouri-Kansas City, School of Medicine
  • Chief Scientific Officer, Pacific Biosciences
  • Research Fellow, Biostatistics & Computational Biology, Dana-Farber Cancer Institute
  • Leon Jaworski Professor of Biomedical Ethics, Director, Center for Medical Ethics and Health Policy, Baylor College of Medicine
  • Professor, Department of Pathology, Director, Genomic Technologies, Center for Advanced Laboratory Medicine, University of California San Diego
  • Postdoctoral Research Fellow, Dana Farber Cancer Institute/Harvard University
  • Head of Genome Sciences, McGill University and Genome Quebec Innovation Centre (MUGQIC), Associate Professor, Human Genetics, Department of Bioengineering
  • Chief Medical Officer, DNAnexus
  • Chief, Division of Medical Genomics, Inova Translational Medicine Institute, Associate Professor, Virginia Commonwealth University School of Medicine
  • Founder & Chief Technology Officer, Synthace Ltd
  • Lead Bioinformatics Scientist, Personalis, Inc.
  • Senior Marketing Specialist, Canon BioMedical
  • Director, Liquid Biopsy and Site Manager, QIAGEN Hannover Germany
  • National Applications Manager, PerkinElmer, chemagen
  • Senior Manager, NGS Applications, DNASTAR
  • Associate Director of Applications, Oxford Nanopore Technologies
  • PhD Student, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
  • Professor of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Hungary.

Show Resources
Agenda
All times are Pacific Time
  • MAY 11, 2016 06:00 AM PDT
    Speaker: David Stoddart, MBioch, DPhil
  • MAY 11, 2016 06:00 AM PDT
    Speaker: Frederick Dewey, MD
  • MAY 11, 2016 07:30 AM PDT
    Speaker: David Bentley, DPhil, FMedSci
  • MAY 11, 2016 09:00 AM PDT
    Speaker: Robert Green
  • MAY 11, 2016 10:30 AM PDT
    Speaker: Aaron Black
  • MAY 11, 2016 10:30 AM PDT
    Speaker: Hugo Aerts, PhD
  • MAY 11, 2016 10:30 AM PDT
    Speaker: Jonas Korlach, PhD
  • MAY 11, 2016 12:00 PM PDT
    Speaker: Matthew Keyser, MS
  • MAY 11, 2016 12:00 PM PDT
    Speaker: Benjamin Solomon, MD
  • MAY 11, 2016 12:00 PM PDT
    Speaker: Weida Tong, PhD
  • MAY 11, 2016 01:30 PM PDT
    Speaker: Ioannis (Jiannis) Ragoussis, PhD
  • MAY 11, 2016 01:30 PM PDT
    Speaker: Emily Farrow, PhD, CGC
  • MAY 11, 2016 01:30 PM PDT
    Speaker: Mick Correll
  • MAY 11, 2016 03:00 PM PDT
    Speaker: Amy McGuire, JD, PhD
  • MAY 12, 2016 06:00 AM PDT
    Speaker: Amalio Telenti MD, PhD
  • MAY 12, 2016 07:30 AM PDT
    Speaker: Alex Lopez, PhD, MBA
  • MAY 12, 2016 07:30 AM PDT
    Speaker: Zsolt Rónai, MD, PhD
  • MAY 12, 2016 07:30 AM PDT
    Speaker: Siegfried Hauch
  • MAY 12, 2016 09:00 AM PDT
    Speaker: Alexander Zaranek, PhD
  • MAY 12, 2016 10:30 AM PDT
    Speaker: Sean Ward
  • MAY 12, 2016 10:30 AM PDT
    Speaker: Marieke Kuijjer, PhD
  • MAY 12, 2016 10:30 AM PDT
    Speaker: Paul Datlinger
  • MAY 12, 2016 12:00 PM PDT
    Speaker: Sarah Murray, PhD
  • MAY 12, 2016 12:00 PM PDT
    Speaker: John Platig, PhD
  • MAY 12, 2016 12:00 PM PDT
    Speaker: David Shaywitz, MD, PhD
  • MAY 12, 2016 01:30 PM PDT
    Speaker: Brian McNally, PhD
  • MAY 12, 2016 01:30 PM PDT
    Speaker: Elena Helman, PhD
  • MAY 12, 2016 03:00 PM PDT
    Speaker: Rong Chen, PhD
  • Industry
  • MAY 11, 2016 06:00 AM PDT
    Speaker: David Stoddart, MBioch, DPhil
  • MAY 11, 2016 12:00 PM PDT
    Speaker: Matthew Keyser, MS
  • MAY 12, 2016 07:30 AM PDT
    Speaker: Alex Lopez, PhD, MBA
  • MAY 12, 2016 07:30 AM PDT
    Speaker: Siegfried Hauch
  • MAY 12, 2016 10:30 AM PDT
    Speaker: Paul Datlinger
  • MAY 12, 2016 01:30 PM PDT
    Speaker: Brian McNally, PhD
  • MAY 12, 2016 01:30 PM PDT
    Speaker: Elena Helman, PhD
  • Innovations in Genomic Tools and Technologies
  • MAY 11, 2016 06:00 AM PDT
    Speaker: Frederick Dewey, MD
  • MAY 11, 2016 09:00 AM PDT
    Speaker: Robert Green
  • MAY 12, 2016 06:00 AM PDT
    Speaker: Amalio Telenti MD, PhD
  • MAY 12, 2016 07:30 AM PDT
    Speaker: Zsolt Rónai, MD, PhD
  • MAY 12, 2016 10:30 AM PDT
    Speaker: Sean Ward
  • Genomics in the Clinic
  • MAY 11, 2016 07:30 AM PDT
    Speaker: David Bentley, DPhil, FMedSci
  • MAY 11, 2016 10:30 AM PDT
    Speaker: Aaron Black
  • MAY 11, 2016 12:00 PM PDT
    Speaker: Benjamin Solomon, MD
  • MAY 11, 2016 01:30 PM PDT
    Speaker: Emily Farrow, PhD, CGC
  • MAY 11, 2016 03:00 PM PDT
    Speaker: Amy McGuire, JD, PhD
  • MAY 12, 2016 10:30 AM PDT
    Speaker: Marieke Kuijjer, PhD
  • MAY 12, 2016 12:00 PM PDT
    Speaker: Sarah Murray, PhD
  • Clinical Utility of the Newest Technologies
  • MAY 11, 2016 10:30 AM PDT
    Speaker: Hugo Aerts, PhD
  • MAY 11, 2016 12:00 PM PDT
    Speaker: Weida Tong, PhD
  • MAY 11, 2016 01:30 PM PDT
    Speaker: Mick Correll
  • MAY 12, 2016 12:00 PM PDT
    Speaker: John Platig, PhD
  • -Omics in Health and Disease
  • MAY 11, 2016 10:30 AM PDT
    Speaker: Jonas Korlach, PhD
  • MAY 11, 2016 01:30 PM PDT
    Speaker: Ioannis (Jiannis) Ragoussis, PhD
  • MAY 12, 2016 09:00 AM PDT
    Speaker: Alexander Zaranek, PhD
  • MAY 12, 2016 12:00 PM PDT
    Speaker: David Shaywitz, MD, PhD
  • MAY 12, 2016 03:00 PM PDT
    Speaker: Rong Chen, PhD
Speakers

  • Robert Green
    Director, G2P Research Program (genomes2people.org), Division of Genetics, Brigham and Women's Hospital, Broad Institute, Harvard Medical School
    Biography
      Robert C. Green, MD, MPH is a medical geneticist and physician-scientist who directs the G2P Research Program (genomes2people.org) in translational genomics and health outcomes in the Division of Genetics at Brigham and Women's Hospital, the Broad Institute and Harvard Medical School. Dr. Green is internationally recognized for designing and conducting empirical research that is accelerating the responsible implementation of genomic medicine. He led the first experimental trials disclosing common complex disease risk (the REVEAL Study) and one of the first prospective studies of direct-to-consumer genetic testing services (the PGen Study). He currently leads and co-leads the first randomized trials to explore the implementation of medical sequencing in adults (the MedSeq Project) and newborns (the BabySeq Project), respectively.
    • David Bentley, DPhil, FMedSci
      Vice President & Chief Scientist, Illumina Inc.
      Biography
        David graduated with an M.A. in Natural Sciences from Cambridge and a D.Phil from Oxford. During his career he has been a Senior Lecturer at London University; and later the Head of Human Genetics and a founder member of the Board of Management at the Sanger Centre. David has played a leading role in the Human Genome Project and related international consortia to characterise human sequence variation, including The SNP Consortium and the HapMap Project. His long-term interest is the study of human sequence variation and its impact on human health and disease. His current research is focussed on fast, accurate sequencing of human genomes for adoption and benefit in healthcare.
      • Alexander Zaranek, PhD
        Director, Informatics, Harvard Personal Genome Project, Chief Scientist and Co-founder, Curoverse
        Biography
          Alexander (Sasha) Wait Zaranek, PhD is co-founder and Chief Scientist at Curoverse, a venture-backed company focused on building a free and open-source platform for storing, analyzing and sharing biomedical data. Sasha works on open technologies that are part of the revolution that reduced human DNA sequencing costs by a million-fold since the completion of the Human Genome Project. A current research focus is the development of clinical-quality applications for processing massive data sets spanning millions of individuals across collaborating organizations, eventually encompassing exabytes of data. His contributions have led to highly cited publications in Science, Nature, the Lancet and other leading scientific journals. Sasha is also a co-founder and Director of Informatics at the Harvard Personal Genome Project.
        • Frederick Dewey, MD
          Head of Translational Genetics, Regeneron Genetics Center
          Biography
            Frederick Dewey received his AB in Chemistry and Physics from Harvard University, and MD, with concentration in cardiovascular and pulmonary sciences, from Stanford University. He received clinical training in internal medicine and cardiovascular medicine at Stanford Hospital and Clinics, and research training in human genetics via the Stanford Clinical Investigator Pathway. His research work has focused on gene discovery in familial and complex cardiovascular disease using high throughput sequencing, and application of exome and genome sequencing in clinical care. He joined the Regeneron Genetics Center, a wholly-owned subsidiary of Regeneron Pharmaceuticals, in 2014 and currently leads the Translational Genetics group.
          • Amalio Telenti MD, PhD
            Head of Genomics, Human Longevity, Inc., Research Scientist, J Craig Venter Institute
            Biography
              Amalio Telenti is head of genomics at Human Longevity. He directs a team working on genetics (annotation of genome reports, pharmacogenetics) and genomics (reference genomes, analysis of non-coding genome regions, and data integration). Recently, he led the analysis of the first 10,000 genomes sequenced at HLI. A. Telenti trained in internal medicine and infectious diseases at the Mayo Clinic (Rochester, MN), and in microbiology and genetics at the University of Berne, Switzerland, at the Albert Einstein College of Medicine (Bronx, NY), and at the Ragon Institute of MGH, MIT and Harvard (Boston, MA). Between 2007 and 2014 he was professor and director of the Institute of Microbiology at the University of Lausanne, Switzerland. He has published extensively and received many national and international awards, including the prestigious Cloëtta Award, one of the highest distinctions in medicine in Switzerland. In 2012, he was elected member of the Swiss Academy of Medical Sciences. He maintains academic affiliations with the J. Craig Venter Institute and with the Department of Medicine, University of California San Diego.
            • Weida Tong, PhD
              Director, Division of Bioinformatics and Biostatistics, National Center for Toxicological Research (NCTR), FDA
              Biography
                Dr. Tong is Director of Division of Bioinformatics and Biostatistics at FDA's National Center for Toxicological Research (NCTR/FDA). He has served a science advisory board member for several large projects involving multiple institutes in Europe and USA. He also holds several adjunct positions at universities in US and China. His division at FDA is to develop bioinformatic methodologies and standards to support FDA research and regulation and to advance regulatory science and personalized medicine. The most visible projects from his group are (1) leading the Microarray Quality Control (MAQC) consortium to develop standard analysis protocols and quality control metrics for emerging technologies to support regulatory science and precision medicine; (2) development of liver toxicity knowledge base (LTKB) for drug safety; (4) in silico drug repositioning for the enhanced treatment of rare diseases; and (4) development of the FDA bioinformatics system, ArrayTrackTM suite, to support FDA review and research on pharmacogenomics. In addition, his group also specializes in molecular modeling and QSARs with specific interest in estrogen, androgen, and endocrine disruptor. Dr. Tong has published more than 200 papers and book chapters.
              • Hugo Aerts, PhD
                Director/PI, Computational Imaging and Bioinformatics Laboratory (CIBL), Assistant Professor of Radiation Oncology, Harvard Medical School, Brigham and Women's Hospital, Dana Farber Cancer In
                Biography
                  Dr. Aerts is Director of the Computational Imaging and Bioinformatics Laboratory (CIBL) at Harvard-DFCI. Dr. Aerts' group focuses on the development and application of advanced computational approaches applied to medical imaging data, pathology, and genomic data. Furthermore, he is a PI-member of the Quantitative Imaging Network (QIN) and Informatics Technology for Cancer Research (ITCR) initiative of the NIH.
                • Aaron Black
                  Director, Informatics, Inova Health
                  Biography
                    Mr. Black has more than 15 years of IT and business experience consolidating and managing large and complex data sets from disparate sources. He holds many certifications in both technical and project management. At ITMI, Mr. Black and his team are building a world-class bioinformatics infrastructure for the Institute's massive and varied data to support genomics research and clinical services - and ultimately for the purpose of translating genomics research for medical discoveries and improved patient care. Previously Mr. Black was the informatics manager and leader for the Biospecimen Core Resource at Nationwide Children's Hospital and the National Cancer Institute's Cancer Genome Atlas project. He was co-architect for the flexible data model to store and access data from studies for more than 30 cancer subtypes and clinical data from biobanks and academic institutions across five continents.
                  • Rong Chen, PhD
                    Assistant Professor, Director of Clinical Genome Informatics, Department of Genetics and Genomic Sciences, Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mou
                    Biography
                      r. Chen is Director of Clinical Genome Informatics (http://rongchenlab.org) at Icahn Institute of Genetics and Multiscale Biology. His research focuses on developing databases, genome repositories, and clinical applications to interpret personal genomes for clinical diagnosis, precision medicine, predictive disease risk, and novel therapeutics. Prior to Mount Sinai, he led the collaborative efforts at Stanford University to drive personalized medicine and clinical diagnosis on Mendelian and complex diseases using genome and exome sequencing. Dr. Chen also helped launch a startup company Personalis, which won the VA's contract for the Million Veteran Genome project. Dr. Chen has a broad interest in translational bioinformatics and genome interpretation, and has published over 80 papers in Lancet, Cell, Nature Biotechnology, Nature Methods, Science Translational Medicine, PNAS, AJHG, JCI, PLoS Genetics, PLoS Computational Biology, Genome Research, Genome Biology, Genome Medicine, and AJT. He holds numerous patents for software and databases on personalized medicine, diagnosis, and structure modeling.
                    • Mick Correll
                      Chief Executive Officer, Genospace
                      Biography
                        Mick's 15+ year career has tracked the path of genomics from basic research to clinical care. Over this time he has held leadership positions in academia and industry, and has developed informatics solutions for pharma/biotech R&D, ag-bio, and academic, government, and community healthcare providers. Prior to launching Genospace, he and partner John Quackenbush established the Center for Cancer Computational Biology at the Dana-Farber Cancer Institute. Mick began his career at Lion Bioscience Research Inc. and UK-based informatics provider InforSense. Mick earned a BS in computer science and a BA in molecular biology from the University of Colorado at Boulder.
                      • Emily Farrow, PhD, CGC
                        Director of Laboratory Operations, Center for Pediatric Genomic Medicine, Children's Mercy Hospital, Assistant Professor, University of Missouri-Kansas City, School of Medicine
                        Biography
                          Emily Farrow joined the Center as a research scientist in February 2012. She is an assistant Professor at the University of Missouri-Kansas City School of Medicine and has a secondary appointment at the Indiana University School of Medicine in the Department of Medical and Molecular Genetics. She obtained her M.S. in Genetic Counseling from the Indiana University School of Medicine in 2006 followed by her Ph.D. in Molecular Genetics in 2009. She completed a postdoctoral fellowship supported by a National Kidney Foundation research grant in phosphate regulation at Indiana University School of Medicine. Dr. Farrow is also a board certified genetic counselor. Her research interests include metabolic bone disorders and the role of genetic counseling in genomic medicine.
                        • Jonas Korlach, PhD
                          Chief Scientific Officer, Pacific Biosciences
                          Biography
                            Jonas Korlach was appointed Chief Scientific Officer of Pacific Biosciences in July 2012. He was previously a Scientific Fellow, supporting commercial development of the PacBio RS II system and performing research aimed at developing new applications for SMRT technologies. He co-invented the SMRT technology with Stephen Turner, Ph.D., Pacific Biosciences Founder and Chief Technology Officer, when the two were graduate students at Cornell University. Dr. Korlach joined Pacific Biosciences as the company's eighth employee in 2004. Previously, he was a Postdoctoral Researcher at Cornell University. Dr. Korlach is the recipient of multiple grants, an inventor on 70 issued U.S. patents and 61 international patents, and an author of over 70 scientific studies on the principles and applications of SMRT technology, including publications in Nature, Science, and PNAS. In 2013, Dr. Korlach was honored by the Obama White House as an Immigrant Innovator "Champion of Change." He received both his Ph.D. and his M.S. degrees in Biochemistry, Molecular and Cell Biology from Cornell, and received M.S. and B.A. degrees in Biological Sciences from Humboldt University in Berlin, Germany.
                          • Marieke Kuijjer, PhD
                            Research Fellow, Biostatistics & Computational Biology, Dana-Farber Cancer Institute
                            Biography
                              Marieke Kuijjer is a postdoctoral fellow in the laboratory of John Quackenbush at the department of Biostatistics and Computational Biology of the Dana-Farber Cancer Institute and the department of Biostatistics of the Harvard T.H. Chan School of Public Health, Boston, MA. She obtained her PhD (2013) in Cancer Genomics from Leiden University Medical Center, Leiden, the Netherlands, working in the department of Pathology on bioinformatics of bone and soft tissue sarcomas. Marieke's research interests focus around developing and using new methods to map the complex patterns that are disrupted in cancer in networks. These range from integrating gene regulation by transcription factors and microRNAs to discover new cancer subtypes and analyzing single-sample networks in the context of cancer prognosis to using networks to model somatic mutations in cancer.
                            • Amy McGuire, JD, PhD
                              Leon Jaworski Professor of Biomedical Ethics, Director, Center for Medical Ethics and Health Policy, Baylor College of Medicine
                              Biography
                                Dr. McGuire is the Leon Jaworski Professor of Biomedical Ethics and Director of the Center for Medical Ethics and Health Policy at Baylor College of Medicine. She is nationally recognized for her research on ethical, legal, and social issues in biomedicine, with a particular focus on research ethics and the clinical integration of emerging genomic technologies. Currently, she is studying issues related to genomic data sharing, the policy implications of emerging business models for next generation sequencing, and the ethics and psychosocial impact of whole genome and whole exome sequencing. Her research is funded by the NIH-NHGRI, NCI, and NICHD. She has served on the National Advisory Council for the Human Genome Research Institute and is currently a member of the Advisory Committee for the Greenwall Faculty Scholars Program in Bioethics. Dr. McGuire is the recipient of two Fulbright & Jaworski LLP Faculty Excellent Awards for Teaching and Evaluation and Educational Leadership. She received her B.A. from the University of Pennsylvania, summa cum laude, her J.D. from the University of Houston Law Center, summa cum laude, and her Ph.D., with distinction, from the Institute for Medical Humanities at the University of Texas Medical Branch.
                              • Sarah Murray, PhD
                                Professor, Department of Pathology, Director, Genomic Technologies, Center for Advanced Laboratory Medicine, University of California San Diego
                                Biography
                                  Dr. Murray is Director of Genomic Technologies at UC San Diego's Center for Advanced Laboratory Medicine (CALM) and Professor in the Department of Pathology. At the CALM, Dr. Murray is involved with the development of advanced genomic technologies for the clinical lab, and oversees the bioinformatics and analysis of genomic data. Prior to coming to UCSD, she was a founding member of the Scripps Translational Science Institute, serving as the institute's Director of Genetics, as well as Associate Professor of Translational Genomics at The Scripps Research Institute. While at Scripps, Dr. Murray directed a high-throughput genotyping and sequencing laboratory aimed at discovering genetic components of various diseases and health, and determining risk profiles based on combinations of specific risk alleles in large prospective studies. From 2003-2007, Dr. Murray was the chief geneticist at Illumina, a San Diego genomics biotech company, where she played a large role in developing the content and design strategy for numerous whole genome genotyping arrays that enabled large-scale genome-wide genetic studies. Dr. Murray has a long history in both theoretical and applied genetics research. She has published over 90 articles in the human genetics literature that focus on the discovery and analysis of DNA sequence polymorphism. Dr. Murray received her Ph.D. from the University of Pittsburgh's Department of Human Genetics, and was a postdoctoral fellow at Case Western Reserve's Department of Genetics. Dr. Murray also has a M.S. degree in genetic counseling from the University of Pittsburgh.
                                • John Platig, PhD
                                  Postdoctoral Research Fellow, Dana Farber Cancer Institute/Harvard University
                                  Biography
                                    John Platig received his PhD in Physics from the University of Maryland. His thesis focused on the applications of complex network methods to biological data sets, with an emphasis on understanding how errors in edge identification affect network properties. In conjunction with his physics training, he was a Cancer Research Training Fellow at the National Cancer Institute, working to identify potential therapeutic targets from a reconstructed gene regulatory network in Diffuse Large B Cell Lymphoma. In 2013 John started as postdoctoral fellow with John Quackenbush at the Dana-Farber Cancer Institute. He is currently working on network inference and clustering methods to better understand genetic and other factors that drive phenotypes.
                                  • Ioannis (Jiannis) Ragoussis, PhD
                                    Head of Genome Sciences, McGill University and Genome Quebec Innovation Centre (MUGQIC), Associate Professor, Human Genetics, Department of Bioengineering
                                    Biography
                                      Ioannis (Jiannis) Ragoussis studied Biochemistry at the University of Tuebingen, Germany, where he obtained his PhD. He did his postdoctoral studies as EMBO fellow with J. Trowsdale at the Imperial Cancer Research Fund Laboratories in London, UK. Subsequently he became lecturer and then senior lecturer at the division of Medical and Molecular Genetics at Guy's Hospital, then Guy's and now King's Medical School. In 2001 he moved to the University of Oxford as Head of Genomics and in 2013 to McGill University where he is Head of Genome Sciences at the McGill University and Genome Quebec Innovation Centre (MUGQIC) and Associate Professor in Human Genetics and at the Department of Bioengineering. He is also affiliated Professor at the Biomedical Sciences research Centre A. Fleming in Greece and the King Abdulaziz University. He has developed expertise in all fields of genomics and functional genomics. His main interest is on developing NGS based approaches to disease gene identification, as well as functional genomics approaches for the identification of prognostic markers and associated pathways in breast cancer. He is responsible for the Genomic Platform Development within the MUGQIC Genome Canada Genome Innovation Node and Canada's Genomics Enterprize funded by CFI. He chairs the internal management committee of MUGQIC, oversees genomic platform operation and new technology evaluation and integration. His Lab works on Technical Developments including the Single Cell Genomics Lab of MUGQIC and Mutation Detection Technologies with focus on the genomic and transcriptomic analysis of single cells. Supported by CF the lab includes a Fluidigm BioMark HD instrument and two Fluidigm C1 instruments, as well as an Oxford Nanopore MinION device. Both single cell whole genome expression profiling as well as whole exome protocols are validated and available for external users.
                                    • David Shaywitz, MD, PhD
                                      Chief Medical Officer, DNAnexus
                                      Biography
                                        As Chief Medical Officer, David is responsible for driving clinical impact, working closely with management and engineering teams, and with external partners and collaborators. Most recently at Theravance Biopharma, David focused on strategy and business development, and led a product team. Prior, he was a management consultant at the Boston Consulting Group, and was an early member of the Department of Experimental Medicine at Merck Research Labs. He was also a founding advisor of Sage Bionetworks, and a co-founder of the MGH/MIT Center for Assessment Technology and Continuous Health (CATCH). David received his M.D. from the Harvard-MIT Division of Health, Science, and Technology at Harvard Medical School, and his Ph.D. from the Department of Biology at MIT. He trained in internal medicine and endocrinology at the Massachusetts General Hospital, and conducted his post-doctoral research in Doug Melton's lab at the Harvard Stem Cell Institute.
                                      • Benjamin Solomon, MD
                                        Chief, Division of Medical Genomics, Inova Translational Medicine Institute, Associate Professor, Virginia Commonwealth University School of Medicine
                                        Biography
                                          Dr. Solomon, an accomplished scientist and medical geneticist, is dual board-certified in pediatrics and clinical genetics through the National Human Genome Research Institute. At Inova Translational Medicine Institute, Dr. Solomon leads the Medical Genomics division - a group of clinicians and researchers that focuses on providing genetic and genomic medical care, discovering new explanations for genetic disorders, and studying the best ways to integrate cutting-edge genomic resources into clinical practice. Previously Dr. Solomon held positions at National Institutes of Health researching the genetic and genomic causes of both rare and common conditions, especially certain types of congenital anomalies. The author of over 70 peer-reviewed articles and book chapters, Dr. Solomon serves as an editor on a number of medical journals, has edited several medical textbooks, and is actively involved in genetic and genomic training and education.
                                        • Sean Ward
                                          Founder & Chief Technology Officer, Synthace Ltd
                                          Biography
                                            Sean is a serial entrepreneur, first in the music industry with Relatable, and currently in synthetic biology with Synthace, where he is the architect and driving force behind Antha, a high level language and operating system for working with biology. Before founding Synthace, Sean was a research associate in bioinformatics at University College London, where he conducted research into protein folding, protein structure prediction, and gene coding. At Relatable, Sean invented audio fingerprinting which was used by major peer-to-peer companies such as Napster. Sean is also an adviser on synthetic biology to the BBSRC, and a SynBioLEAP Fellow.
                                          • Elena Helman, PhD
                                            Lead Bioinformatics Scientist, Personalis, Inc.
                                            Biography
                                              Elena Helman joined Personalis, Inc. in January 2014 as a Bioinformatics Scientist, Technical Lead where she has been instrumental in leading the development of the cancer DNA products and pipeline. This includes designing and implementing a somatic analysis pipeline for cancer exome and targeted gene panel sequencing, including small variant and copy-number calling, variant annotation and reporting. Elena received her PhD in Bioinformatics and Integrative Genomics from Harvard-MIT Division of Health Sciences and Technology (HST). For her graduate work in Matthew Meyerson's Lab at the Broad Institute and Dana Farber Cancer Institute, she developed a novel tool to identify somatic retrotransposon insertions using whole-genome and whole-exome next-generation sequencing data from hundreds of tumor samples across The Cancer Genome Atlas (TCGA).
                                            • Brian McNally, PhD
                                              Senior Marketing Specialist, Canon BioMedical
                                              Biography
                                                Brian McNally received his doctorate in Cell & Molecular Biology at University of Texas Southwestern Medical Center, where he focused on the transcriptional mechanisms governing polycystic kidney disease, renal cancer and development. His post-doctoral fellowship concentrated on the regulatory relationship between the proteasome and Toll-like receptor signaling at the University of Maryland Medical School in the Department of Immunology and Microbiology. Brian has fifteen years of practical experience at the laboratory bench, and his work has been published in peer-reviewed journals and presented at international conferences. In 2008, he transitioned to industry to commercialize new biomedical products including assays, reagents and software. Brian has been with Canon BioMedical since its inception last year. He is passionate about partnering with life scientists to develop the next wave of biomedical solutions.
                                              • Siegfried Hauch
                                                Director, Liquid Biopsy and Site Manager, QIAGEN Hannover Germany
                                                Biography
                                                  Dr. Siegfried Hauch studied biology at the Albert Einstein University in Ulm and received his PhD 1997 in plant physiology and molecular biology at the Eberhard Karls University Tübingen. Until 2001 he was Product Manager for imaging systems and microarray technologies at Biozym Diagnostics GmbH and changed therafter to AdnaGen AG as Marketing Manager in 2001. In addition to his marketing responsibilities he was director of R&D since 2006 to build, secure and enhance the AdnaGen circulating tumor cell business and, after the accquistion by Alere Inc. in 2010, he was holding the position as CSO and General Manager at Alere/AdnaGen GmbH. Since 2015 Dr. Hauch serves as Director of Liquid Biopsy and Site Manager at QIAGEN Hannover GmbH.
                                                • Alex Lopez, PhD, MBA
                                                  National Applications Manager, PerkinElmer, chemagen
                                                  Biography
                                                    Dr. Alex Lopez received his PhD in Biology from Cleveland State University in 2002, with a concentration in Molecular Parasitology and he collected his MBA from Cleveland State University in 2004. He received his Bachelor of Science from The Ohio State University in 1995. He joined chemagen in 2010 and subsequently PerkinElmer in 2011, following the acquisition of chemagen technologies. Prior to that, he worked as a Research Associate for the USDA-ARS at Cornell University and had a Postdoctoral Fellowship at Case Western Reserve University.
                                                  • Matthew Keyser, MS
                                                    Senior Manager, NGS Applications, DNASTAR
                                                    Biography
                                                      Matthew Keyser is Senior Manager, NGS Applications for DNASTAR, where he has helped scientists address their sequence assembly and analysis challenges for the past seven years. Matts sole focus at DNASTAR is supporting customers in next-gen sequencing applications using DNASTARs broad software toolset. Matt helps customers with their templated and de novo assembly projects, transcriptomes, exomes, metagenomic assemblies, RNA-Seq, ChIP-Seq and numerous other unique experiments. Matt has helped hundreds of scientists optimize their workflows using DNASTARs next-gen software solutions. He has also spoken at numerous conferences and workshops regarding the capabilities of DNASTARs next-gen software tools.
                                                    • David Stoddart, MBioch, DPhil
                                                      Associate Director of Applications, Oxford Nanopore Technologies
                                                      Biography
                                                        Having completed my undergraduate degree in 2007 (Wadham College, Oxford) I got the taste for nanopore technology during a brief stint at ONT that Summer. Subsequently, I went to work for Hagan Bayley, obtaining my DPhil, before re-joining the company in 2011 focussing on library preparation development.
                                                      • Paul Datlinger
                                                        PhD Student, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
                                                        Biography
                                                          Paul Datlinger is a PhD student in the lab of Christoph Bock at the Center for Molecular Medicine of the Austrian Academy of Sciences in Vienna, and developer of a high-throughput RRBS protocol, available as a kit from Diagenode. He studied Molecular Biology at the Universities of Vienna, Manchester and at Imperial College London. Besides developing new technologies for next-generation sequencing, his research interests revolve around epigenetic modifier networks, and epigenome editing by exploiting the CRISPR/Cas9 system.
                                                        • Zsolt Rónai, MD, PhD
                                                          Professor of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Hungary.
                                                          Biography
                                                            Dr. Ronai is an Assistant Professor at the Department of Medical Chemistry, Molecular Biology and Pathobiochemistry at Semmelweis Medical University in Hungary, where he also serves as a Principal Investigator focusing on genomic analysis study of type 2 diabetes mellitus and the central nervous system. Dr. Ronai participates in several studies including a Comprehensive Geno-Glycomic Approach to Discovery New Lung Cancer Biomarkers. Previously, he participated in a research investigating the Genetic and Caregiving Effects on Disordered Attachment, a Forgarthy International Research Collaborative study with the Karlen Lyons-Ruth Institute of Psychiatry at Harvard Medical School, Boston, MA. Dr. Ronai received his MD degree in General Medicine at Semmelweis Medical University in Budapest, Hungary and his PhD degree in Pathobiochemistry at the same university.
                                                          Sponsored By

                                                          For information on becoming a sponsor or exhibitor, please click here.


                                                          Continuing Education (CME/CE/CEU) Credits

                                                          The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


                                                          Committee

                                                          To download the Program Committee brochure here.


                                                          • Timothy Harris, PhD

                                                            Since June 2011, Dr. Harris has served as the Senior Vice President of Translational Medicine at Biogen Idec. Dr. Harris has served as the Director of the Advanced Technology Program at SAIC Frederick since 2007 and Chief Technology Officer for SAIC Frederick since 2008. Prior to ...

                                                            See more See less
                                                          • Shawn Baker, PhD

                                                            Dr. Shawn C. Baker is the Chief Science Officer and co-founder of AllSeq. Having received his Ph.D. at the University of California - Davis, he started his career as a Research Scientist at Illumina when it was a 15-person startup. After spending several years at the bench ...

                                                            See more See less
                                                          • Pinar Bayrak-Toydemir, MD, PhD

                                                            Dr. Bayrak-Toydemir is the medical director of the Molecular Genetics and Genomics Laboratories at ARUP and an associate professor of pathology at the University of Utah School of Medicine. Dr. Bayrak-Toydemir received her MD from the Ankara University School of Medicine in ...

                                                            See more See less
                                                          • Charles Cantor, PhD

                                                            Dr. Charles Cantor is a founder, and Chief Scientific Officer at SEQUENOM, Inc., which is a genetics discovery company with tools, information and strategies for determining the medical impact of genes and genetic variations. He is also the founder of SelectX Pharmaceuticals ...

                                                            See more See less
                                                          • Pierre-Antoine Gourraud, PhD, MPH

                                                            Pierre-Antoine Gourraud is a former student of the Ecole Normale Suprieure de Lyon in France. After receiving an M.P.H. from University Paris XIII in 2002, he got his Ph.D. in Immunogenetic Epidemiology and Public Health from Toulouse University in 2005. He relocated to the ...

                                                            See more See less
                                                          • Agnieszka Lichanzka Ph.D.

                                                            Agnieszka is currently a Staff Scientist and Laboratory Manager at TessArae, LLC in Sterling, VA, USA. She obtained her PhD at the University of Queensland in Australia in a field of biochemistry, and subsequently worked as a post-doctoral fellow at Queen's University of Belfast ...

                                                            See more See less
                                                          • C Jimmy Lin, MD, PhD, MHS

                                                            Jimmy Lin, MD, PhD, MHS, is a 2012 TED Fellow and Founder & President of Rare Genomics Institute, the world's first platform to enable any community to leverage cutting-edge biotechnology to advance understanding of any rare disease. Partnering with 18 of the top medical ...

                                                            See more See less
                                                          • Vincent Mauro, Ph.D.

                                                            Dr. Mauro is an Associate Professor in the Department of Neurobiology at the Scripps Research Institute in La Jolla, California. He is also a co-founder and lead scientist of Promosome, a biotechnology company focused on bioproduction enablement and DNA vaccines. In addition, Dr ...

                                                            See more See less
                                                          • John Quackenbush, PhD

                                                            John Quackenbush received his PhD in 1990 in theoretical physics from UCLA working on string theory models. Following two years as a postdoctoral fellow in physics, Dr. Quackenbush applied for and received a Special Emphasis Research Career Award from the National Center for ...

                                                            See more See less
                                                          • Deanne Taylor, MS, PhD

                                                            Dr. Taylors background is in biophysics, bioinformatics, computational biology and structural biology with emphasis on human genetics and translational medicine. She obtained her Ph.D. in Biophysics from the University of Michigan, Ann Arbor, and completed a postdoctoral ...

                                                            See more See less
                                                          • Yue Wan, PhD

                                                            Yue Wan received her B.Sc in Cell Biology and Biochemistry from the University of California, San Diego. She obtained her Ph.D in Cancer Biology Stanford University, California, USA, under the mentorship of Howard Y. Chang. During her PhD, she developed the first ...

                                                            See more See less
                                                          Help

                                                          General LabRoots Questions

                                                          For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                                                          Contact us

                                                          Virtual Events and Webinars

                                                          Supported Configurations

                                                          • Operating System Internet Explorer Firefox Chrome Safari
                                                            Vista IE8+ FF10+ Chrome15+
                                                            Windows 7 IE8+ FF10+ Chrome15+
                                                            Windows 8 IE10 FF10+ Chrome15+
                                                            Mac OS X   FF10+ Chrome15+ Safari5.1+
                                                          • Cookie settings: session cookies enabled
                                                          • Browser configuration must have JavaScript enabled
                                                          • Adobe Flash player 10.2 or later

                                                          To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                                          Internet Connection

                                                          • A minimum of 100Kbps is recommended for audio-only events
                                                          • A minimum of 300Kbps is recommended for speaker on-video events

                                                          Computer Equipment

                                                          • Screen Resolution: Minimum 1024x768
                                                          • Video Card: 65,000 colors minimum
                                                          • Sound card and speakers (or headphones) for hearing webcast in full format
                                                          • Audio Card: 16-bit minimum
                                                          • RAM: 512MB of free RAM

                                                          Firewall Protocol

                                                          • HTTP on port 80 or HTTPS on port 443
                                                          • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                                          • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                                          Work-At-Home Attendees

                                                          • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                                          For A Seamless Experience

                                                          When using a mobile device, FREE Mobile Apps are available:

                                                          - For viewing Webinars:

                                                          - For viewing Virtual Events

                                                          Attendee Guide

                                                          • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                                          Virtual Event and Webinar Support:

                                                          Continuing Education (CME/CE) Support

                                                          Loading Comments...
                                                          Show Resources